BIND Therapeutics: BioCentury Newsmakers in the Biotech Industry (BIND Therapeutics) - Sep 12, 2015 - Anticipated data readout from P2 iNSITE 1 trial (NCT02283320) in KRAS mutant NSCLC in H2 2015/H1 2016; Anticipated data readout from P2 iNSITE 1 trial in squamous histology NSCLC in H2 2015/H1 2016
Anticipated P2 data • Non Small Cell Lung Cancer • Oncology
|